Alliance
  • Our Purpose
  • Our Impact
  • How We Operate
  • News & Resources
  • Let’s Collaborate
Select Page
Nonprofit Drug Maker to Begin Manufacturing This Year at $140m Petersburg Plant

Nonprofit Drug Maker to Begin Manufacturing This Year at $140m Petersburg Plant

Jan 23, 2023 | In the News

Nonprofit Drug Maker to Begin Manufacturing This Year at $140m Petersburg Plant SOURCE Richmond BizSense by Jack Jacobs IMAGE by Civica Rx “A Utah-based nonprofit pharmaceutical manufacturer is gearing up to kick off production at its new Petersburg plant about...
Phlow and Maryland Nonprofit Opening Shared Lab in Richmond

Phlow and Maryland Nonprofit Opening Shared Lab in Richmond

Dec 13, 2022 | In the News

Phlow and Maryland Nonprofit Opening Shared Lab in Richmond SOURCE Richmond BizSense by Jack Jacobs IMAGEby Jack Jacobs “A newly announced pharmaceutical lab facility is expanding a local company’s footprint while introducing a newcomer to the area. Shockoe...
Phlow Corp., U.S. Pharmacopeia Open Richmond Labs to Develop Pharma Techniques

Phlow Corp., U.S. Pharmacopeia Open Richmond Labs to Develop Pharma Techniques

Dec 13, 2022 | In the News

Phlow Corp., U.S. Pharmacopeia Open Richmond Labs to Develop Pharma Techniques SOURCE Richmond Times-Dispatch by Sean Jones IMAGEby EVA RUSSO/TIMES-DISPATCH   “The Richmond-area partnership that’s been working since 2020 to revolutionize U.S. drug making...
Joy Marie Polefrone Lays Out Her Vision for the Alliance for Building Better Medicine

Joy Marie Polefrone Lays Out Her Vision for the Alliance for Building Better Medicine

Dec 7, 2022 | In the News

Joy Marie Polefrone Lays Out Her Vision for the Alliance for Building Better Medicine SOURCE The Business Journals by James Shea — Richmond Inno “Joy Marie Polefrone earned a doctorate in chemistry from the University of Virginia and traveled the world as an...
Pharma partnership to get boost with new labs in Richmond, Chesterfield

Pharma partnership to get boost with new labs in Richmond, Chesterfield

Sep 9, 2022 | In the News

Pharma partnership to get boost with new labs in Richmond, Chesterfield SOURCE Richmond BizSense by Jack Jacobs IMAGE SOURCEJack Jacobs “Two sizable new laboratory buildings tied to a regional effort to manufacture pharmaceuticals are set to rise in Richmond and...
Governor proclaims ‘Essential Medicine Shortage Awareness Day’

Governor proclaims ‘Essential Medicine Shortage Awareness Day’

Sep 8, 2022 | In the News

Governor proclaims ‘Essential Medicine Shortage Awareness Day’ SOURCE The Progress-Index Gov. Glenn Youngkin presented an ‘Essential Medicine Shortage Awareness Day’ proclamation to the stakeholders in the Petersburg-Richmond pharma...
« Older Entries

Recent Posts

  • Nonprofit Drug Maker to Begin Manufacturing This Year at $140m Petersburg Plant
  • Phlow and Maryland Nonprofit Opening Shared Lab in Richmond
  • Phlow Corp., U.S. Pharmacopeia Open Richmond Labs to Develop Pharma Techniques
  • Joy Marie Polefrone Lays Out Her Vision for the Alliance for Building Better Medicine
  • Alliance for Building Better Medicine Names Joy Polefrone as Executive Director

Recent Comments

No comments to show.

Our Purpose

Our Impact

How We Operate

In the News

Let’s Collaborate

We Are Building Better Medicine

Address



800 E Leigh St
Richmond, VA 23219

Contact Us


(804) 828-5390


joy@buildingbettermedicine.com

Follow Us

  • Follow
  • Follow
  • Follow

No Boundaries, Just Impact

Our alliance does not define itself by lines on a map, partisanship, or titles. We are an ecosystem without “ego.” Our lifesaving results are the true form of measurement for the impact we deliver to the world.

Reimagining Manufacturing Processes

We are reimagining manufacturing processes, creating new methods, and co-developing novel pharmaceutical products. The core differentiator that sets our ecosystem apart is our alliance’s ability to rethink the entire process for creating essential medicines – from starting ingredients to medicine cabinet. We drive down costs and drive-up quality as a result of our collective efforts to create and leverage new technologies that bring only the highest-quality medicines, once in shortage, to market in record time.

Radical Collaboration

We believe in radical collaboration and participation at all times. This shared commitment is what our alliance is built upon, and it can be measured by our ability to bring together the most innovative pharmaceutical leaders and unique public-private partnerships to define a new era of health and wellness and to restore U.S. global competitiveness.

Always Building Better Medicine

Always building better medicine is fundamental to our success. Better means safer, affordable, and readily available. Better means having reliable access to medications once in chronic shortage. And it means creating medicine quickly and efficiently in a fashion that has the least impact on our planet as possible. As an alliance, we build better medicine through excellence in execution, our ability to attract ongoing public and private investment, our commitment to the communities we serve, and our ability to protect the pharmaceutical supply chain.

For the Region, For the World

Accelerating our region, our country, and our planet forward at all times can be found at the heart of everything we do. We serve as a catalyst for a globally competitive pharmaceutical manufacturing and R&D industry that spans 17 cities and counties in our region, we form ongoing partnerships with economic development agencies and industry partners, we empower manufacturers to grow and to create opportunities for 21st-century workforce development, we commercialize our shared discoveries, and we always strive to inspire further invention and investment.

Committed to Co-Investing

We are committed to co-investing and attracting outside investment. The impact created by our alliance is the direct result of co-investments from the federal government, state and local government, private sector, and other partners all working to grow through a sustainable, fiscally responsible model of collaboration.

Quadruple Bottom Line

The industry ecosystem we have created in the Commonwealth of Virginia gauges its success using four dimensions of performance: health, social, environmental, and financial impact. We are holistic – addressing multiple, interconnected priorities such as translational research that sparks engineering research, strengthening degree programs and our higher education network, creating opportunities for 21st-century workforce development in life science/advanced pharmaceutical manufacturing, creating higher-paying jobs, producing medicine using environmentally friendly methods, enhancing Virginia’s competitiveness across the globe, attracting other suppliers, improving health and wellness, and more.